Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Abivax SA American Depositary Shares

ABVX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
ABVX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ABVX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ABVX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ABVX holdings by institutional investors

Quarterly net insider trading by ABVX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ABVX

Quiver Logo

No former government officials on record as having lobbied for ABVX

Revolving Door Dashboard

ABVX Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ABVX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ABVX Income Statement
ABVX Balance Sheet
ABVX Cash Flow
U.S. Patents

New ABVX patent grants

  • Patent Title: Substituted imidazolidines for treating a rna virus infection May. 05, 2026
  • Patent Title: Phenyl-n-quinoline derivatives for treating a rna virus infection Nov. 25, 2025
  • Patent Title: Aryl-n-aryl derivatives for treating a rna virus infection Sep. 23, 2025
  • Patent Title: Aryl-n-aryl derivatives for treating a rna virus infection Mar. 11, 2025
  • Patent Title: In vitro or ex vivo methods for screening a quinoline derivative Jan. 21, 2025
  • Patent Title: Phenyl-n-quinoline derivatives for treating a rna virus infection Sep. 10, 2024
  • Patent Title: Quinoline derivatives for use in the treatment of inflammation diseases May. 28, 2024
  • Patent Title: Combinations including abx196 for the treatment of cancer Nov. 28, 2023
  • Patent Title: Aryl-n-aryl derivatives for treating a rna virus infection Aug. 29, 2023
  • Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases May. 16, 2023
  • Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases May. 16, 2023
  • Patent Title: Mirna-124 as a biomarker Sep. 13, 2022
  • Patent Title: Compounds useful for treating cancer Aug. 30, 2022
  • Patent Title: Combinations including abx196 for the treatment of cancer Mar. 22, 2022
  • Patent Title: Abx196 for use in the treatment of bladder cancer Mar. 08, 2022
  • Patent Title: Compounds and pharmaceutical compositions containing at least one of the compounds May. 25, 2021
  • Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases Apr. 20, 2021
  • Patent Title: Compound, and production method thereof, and methods of treatment using the compound Apr. 13, 2021
  • Patent Title: Method of preparation of alpha galactosyl ceramides compounds Dec. 22, 2020
  • Patent Title: Quinoline derivatives for use in the treatment or prevention of viral infection Oct. 20, 2020
  • Patent Title: Compounds useful for treating cancer Jul. 21, 2020
  • Patent Title: Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging Jun. 16, 2020
  • Patent Title: Compounds for use as therapeutic agents affecting p53 expression and/or activity Jan. 21, 2020
  • Patent Title: Quinoline derivatives for the treatment of inflammatory diseases Oct. 08, 2019
  • Patent Title: Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging Apr. 09, 2019
  • Patent Title: Compounds useful for treating aids Jul. 10, 2018
  • Patent Title: Compounds useful for treating cancer May. 15, 2018
  • Patent Title: Compounds useful for treating aids Mar. 06, 2018
  • Patent Title: Compounds for use as therapeutic agents affecting p53 expression and/or activity Feb. 13, 2018
  • Patent Title: Compounds useful for treating diseases caused by retroviruses Nov. 28, 2017
  • Patent Title: Compounds for treating cancer May. 02, 2017
  • Patent Title: Use of rbm39 as a biomaker Jan. 31, 2017
  • Patent Title: Vaccine composition for use against influenza Dec. 29, 2015
  • Patent Title: Compounds useful for treating aids Sep. 29, 2015
  • Patent Title: Compounds useful for treating cancer Aug. 18, 2015
  • Patent Title: Compounds useful for treating aids Jun. 23, 2015
  • Patent Title: Methods of enhancing adjuvaticity of vaccine compositions Dec. 23, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ABVX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ABVX News

Recent insights relating to ABVX

CNBC Recommendations

Recent picks made for ABVX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ABVX

ABVX Analyst Ratings

ABVX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ABVX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ABVX stock a Buy, Sell, or Hold?

  • What is the price target for $ABVX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ABVX Top Shareholders
Shareholder
Shares Held
ABVX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ABVX stock?

  • Who owns the most shares of $ABVX stock?

  • What funds own $ABVX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ABVX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ABVX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ABVX

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Abivax SA American Depositary Shares (ABVX) Historical Stock Prices

Abivax SA American Depositary Shares (ABVX) closed at $94.13 on September 23, 2026. Over the past year its adjusted close ranged from $72.50 to $145.31. Daily prices go back to October 20, 2023, 733 trading days in all.

  • 1 month-18.96%
  • 3 months+1.75%
  • Year to date-30.20%
  • 1 year+14.76%
  • 3 years
  • 5 years
  • Max+1,034.10%
See every congressional and insider trade on the ABVX price chart

Quiver Premium charts ABVX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 98.30 98.50 92.57 94.13 94.13 2,637,352
Sep 22, 2026 102.74 102.74 96.74 98.29 98.29 2,531,680
Sep 21, 2026 105.72 105.72 102.52 103.45 103.45 974,843
Sep 18, 2026 107.00 107.19 103.89 105.04 105.04 876,033
Sep 17, 2026 104.59 107.60 104.15 106.99 106.99 1,152,158
Sep 16, 2026 106.38 107.16 101.29 102.23 102.23 1,894,356
Sep 15, 2026 113.00 113.11 106.00 106.66 106.66 2,008,012
Sep 14, 2026 116.66 117.14 113.20 113.58 113.58 1,156,685
Sep 11, 2026 115.46 119.02 114.68 118.64 118.64 893,452
Sep 10, 2026 117.80 118.75 114.30 115.95 115.95 1,289,404
Sep 9, 2026 118.19 120.63 116.62 119.46 119.46 987,184
Sep 8, 2026 114.00 120.30 112.95 118.95 118.95 1,605,554
Sep 4, 2026 114.15 115.33 112.78 114.79 114.79 489,816
Sep 3, 2026 112.31 116.10 112.10 114.03 114.03 1,111,818
Sep 2, 2026 114.37 115.66 111.01 111.08 111.08 868,278
Sep 1, 2026 111.00 115.11 110.22 113.67 113.67 991,485
Aug 31, 2026 112.17 114.33 111.36 111.73 111.73 1,056,740
Aug 28, 2026 114.34 115.17 111.72 113.35 113.35 926,192
Aug 27, 2026 116.69 117.24 114.18 114.30 114.30 1,074,405
Aug 26, 2026 117.00 118.00 116.01 116.52 116.52 512,036
Aug 25, 2026 118.19 121.45 117.66 117.93 117.93 853,504
Aug 24, 2026 114.00 116.22 113.29 116.15 116.15 1,293,320
Aug 21, 2026 117.69 120.26 114.50 114.95 114.95 988,635
Aug 20, 2026 120.00 120.11 116.20 118.19 118.19 1,193,475
Aug 19, 2026 120.33 121.08 119.08 120.56 120.56 637,080
Aug 18, 2026 120.00 121.25 118.50 118.94 118.94 482,010
Aug 17, 2026 118.88 123.42 118.72 120.73 120.73 894,804
Aug 14, 2026 120.74 121.97 117.90 118.96 118.96 903,834
Aug 13, 2026 126.28 126.28 120.55 121.45 121.45 812,802
Aug 12, 2026 126.81 128.19 125.22 125.52 125.52 525,367
Aug 11, 2026 127.85 128.50 125.08 126.81 126.81 466,237
Aug 10, 2026 129.92 130.50 127.12 127.50 127.50 763,961
Aug 7, 2026 132.05 133.52 130.01 130.93 130.93 1,100,268
Aug 6, 2026 126.00 131.25 125.64 130.00 130.00 1,076,013
Aug 5, 2026 126.39 130.07 125.17 125.39 125.39 660,074
Aug 4, 2026 125.01 126.00 123.84 125.19 125.19 634,914
Aug 3, 2026 120.40 126.00 119.53 124.78 124.78 941,540
Jul 31, 2026 127.26 127.51 120.62 124.92 124.92 1,237,666
Jul 30, 2026 119.60 125.39 119.00 124.33 124.33 1,493,059
Jul 29, 2026 124.90 125.24 118.18 118.84 118.84 1,150,516
Jul 28, 2026 126.21 126.50 121.70 124.23 124.23 1,016,698
Jul 27, 2026 125.93 130.00 124.00 128.00 128.00 662,347
Jul 24, 2026 133.15 133.23 125.68 125.70 125.70 950,969
Jul 23, 2026 128.27 131.41 127.42 131.16 131.16 750,455
Jul 22, 2026 133.02 134.00 129.11 129.73 129.73 699,912
Jul 21, 2026 131.78 134.74 131.09 134.09 134.09 752,270
Jul 20, 2026 137.00 138.32 130.85 131.50 131.50 1,092,974
Jul 17, 2026 136.07 138.36 134.00 136.65 136.65 1,408,312
Jul 16, 2026 134.50 139.40 133.00 137.77 137.77 1,556,937
Jul 15, 2026 134.10 137.32 133.38 136.94 136.94 934,623
Jul 14, 2026 138.00 138.00 134.60 134.91 134.91 933,134
Jul 13, 2026 137.29 138.75 134.60 135.98 135.98 1,034,979
Jul 10, 2026 140.74 141.00 137.72 139.90 139.90 837,743
Jul 9, 2026 139.00 141.99 138.50 140.74 140.74 907,625
Jul 8, 2026 140.81 141.75 136.85 138.54 138.54 1,261,194
Jul 7, 2026 142.50 145.01 140.56 142.17 142.17 1,356,109
Jul 6, 2026 146.15 147.98 143.03 143.99 143.99 1,544,907
Jul 2, 2026 138.87 146.68 137.63 144.65 144.65 4,015,790
Jul 1, 2026 138.00 139.35 131.86 132.56 132.56 4,790,239
Jun 30, 2026 130.90 137.11 128.19 133.26 133.26 8,949,464
Jun 29, 2026 98.39 99.06 93.05 96.15 96.15 2,771,894
Jun 26, 2026 93.02 99.23 93.02 97.50 97.50 1,666,908
Jun 25, 2026 90.14 93.20 87.01 92.37 92.37 1,771,883
Jun 24, 2026 97.94 98.46 74.79 92.51 92.51 6,728,661
Jun 23, 2026 101.71 102.24 97.20 98.43 98.43 1,561,913
Jun 22, 2026 99.10 103.83 97.50 101.66 101.66 2,237,686
Jun 18, 2026 100.55 101.49 97.83 99.15 99.15 1,701,700
Jun 17, 2026 97.62 103.71 96.00 100.15 100.15 1,731,309
Jun 16, 2026 99.00 101.16 96.06 97.50 97.50 1,944,988
Jun 15, 2026 99.60 103.93 95.70 98.26 98.26 2,123,977
Jun 12, 2026 99.41 100.90 96.21 96.55 96.55 1,164,026
Jun 11, 2026 96.76 101.47 95.87 100.87 100.87 1,175,548
Jun 10, 2026 101.89 101.90 96.77 98.03 98.03 1,363,745
Jun 9, 2026 101.40 103.03 96.84 102.72 102.72 1,182,958
Jun 8, 2026 101.80 105.43 96.00 101.53 101.53 1,821,845
Jun 5, 2026 105.18 108.17 98.23 101.53 101.53 2,625,320
Jun 4, 2026 93.30 105.65 92.65 104.93 104.93 5,267,471
Jun 3, 2026 81.26 92.14 80.77 90.15 90.15 7,165,717
Jun 2, 2026 77.53 83.34 69.81 72.50 72.50 16,115,575
Jun 1, 2026 133.15 133.27 128.37 129.69 129.69 8,092,794
May 29, 2026 130.61 133.50 127.89 132.63 132.63 1,886,466
May 28, 2026 133.64 135.07 129.11 129.50 129.50 1,167,653
May 27, 2026 128.10 131.28 126.00 129.73 129.73 1,082,597
May 26, 2026 126.63 128.47 120.80 126.41 126.41 1,243,541
May 22, 2026 125.00 125.64 120.05 121.99 121.99 1,178,975
May 21, 2026 118.49 126.41 117.00 124.03 124.03 1,667,414
May 20, 2026 115.36 121.00 114.07 119.90 119.90 1,242,586
May 19, 2026 111.50 115.25 109.93 113.73 113.73 1,102,971
May 18, 2026 114.43 115.33 110.82 113.55 113.55 798,157
May 15, 2026 118.85 119.05 114.44 114.53 114.53 943,932
May 14, 2026 121.45 122.34 118.68 121.00 121.00 692,233
May 13, 2026 121.00 123.53 118.81 121.91 121.91 732,312
May 12, 2026 123.11 123.75 120.50 121.39 121.39 734,498
May 11, 2026 122.11 124.39 119.18 122.13 122.13 678,111
May 8, 2026 124.84 126.73 121.21 122.74 122.74 917,598
May 7, 2026 126.56 128.89 124.04 124.65 124.65 1,181,518
May 6, 2026 125.64 129.18 123.45 126.54 126.54 1,240,195
May 5, 2026 124.25 125.36 119.70 123.78 123.78 1,267,922
May 4, 2026 118.31 119.03 114.85 117.13 117.13 654,700
May 1, 2026 117.42 119.06 115.63 117.61 117.61 443,409
Apr 30, 2026 108.49 117.72 108.12 117.38 117.38 1,200,840
Apr 29, 2026 109.87 110.27 106.00 106.24 106.24 890,450
Apr 28, 2026 111.79 114.41 109.77 109.87 109.87 600,314
Apr 27, 2026 112.48 113.68 111.01 111.90 111.90 789,933
Apr 24, 2026 113.00 115.57 110.60 114.56 114.56 889,618
Apr 23, 2026 115.26 116.51 112.77 113.00 113.00 570,625
Apr 22, 2026 113.40 116.00 111.83 115.99 115.99 657,362
Apr 21, 2026 115.01 116.99 111.28 111.43 111.43 756,113
Apr 20, 2026 120.21 120.75 114.90 114.98 114.98 867,652
Apr 17, 2026 125.11 125.72 119.79 120.16 120.16 1,179,004
Apr 16, 2026 121.69 123.19 119.51 122.47 122.47 748,645
Apr 15, 2026 126.50 126.80 119.50 121.48 121.48 985,885
Apr 14, 2026 122.17 127.44 121.03 125.80 125.80 1,050,589
Apr 13, 2026 122.00 126.00 120.19 121.31 121.31 1,511,139
Apr 10, 2026 126.00 128.42 122.55 126.14 126.14 998,599
Apr 9, 2026 119.96 126.00 119.83 125.69 125.69 1,059,005
Apr 8, 2026 120.30 120.75 117.00 118.96 118.96 438,838
Apr 7, 2026 119.06 119.06 113.75 116.48 116.48 393,100
Apr 6, 2026 117.89 120.00 117.00 119.47 119.47 298,351
Apr 2, 2026 112.00 119.79 112.00 118.37 118.37 963,117
Apr 1, 2026 113.21 118.80 113.21 114.97 114.97 1,091,583
Mar 31, 2026 102.39 112.91 102.39 111.35 111.35 1,547,449
Mar 30, 2026 103.50 104.80 100.15 101.50 101.50 762,481
Mar 27, 2026 108.24 108.43 102.00 102.47 102.47 1,757,499
Mar 26, 2026 109.22 111.00 108.23 109.48 109.48 848,699
Mar 25, 2026 112.00 113.75 110.13 110.70 110.70 783,003
Mar 24, 2026 116.16 116.92 109.08 110.17 110.17 2,334,196
Mar 23, 2026 120.63 123.00 115.01 115.42 115.42 1,288,417
Mar 20, 2026 123.99 126.86 120.01 120.34 120.34 1,379,997
Mar 19, 2026 122.50 124.99 120.47 123.03 123.03 735,200
Mar 18, 2026 126.01 126.01 122.26 123.99 123.99 1,175,335
Mar 17, 2026 123.51 127.00 123.31 126.62 126.62 694,014
Mar 16, 2026 119.99 123.72 118.55 122.75 122.75 1,595,896
Mar 13, 2026 117.38 121.29 114.67 115.50 115.50 701,954
Mar 12, 2026 120.23 122.23 111.00 116.98 116.98 2,295,908
Mar 11, 2026 114.01 114.39 110.80 112.31 112.31 699,065
Mar 10, 2026 112.01 116.44 112.01 115.28 115.28 543,771
Mar 9, 2026 108.19 110.22 107.75 109.61 109.61 648,868
Mar 6, 2026 110.75 111.33 108.83 109.33 109.33 823,197
Mar 5, 2026 116.35 116.45 111.25 112.70 112.70 593,103
Mar 4, 2026 111.93 117.49 111.75 116.77 116.77 533,100
Mar 3, 2026 109.72 113.07 105.78 111.10 111.10 1,410,231
Mar 2, 2026 118.28 118.50 112.48 113.11 113.11 1,234,242
Feb 27, 2026 119.80 122.49 119.50 121.28 121.28 554,453
Feb 26, 2026 122.85 122.85 116.54 119.47 119.47 1,052,388
Feb 25, 2026 125.70 127.14 122.16 123.33 123.33 885,304
Feb 24, 2026 130.84 130.89 124.04 128.29 128.29 1,110,021
Feb 23, 2026 128.29 132.92 127.32 132.91 132.91 718,796
Feb 20, 2026 130.45 133.42 129.27 130.35 130.35 740,068
Feb 19, 2026 129.10 132.47 126.90 130.24 130.24 1,049,877
Feb 18, 2026 127.46 130.48 126.01 126.98 126.98 1,176,121
Feb 17, 2026 126.51 127.95 123.94 125.63 125.63 928,502
Feb 13, 2026 124.01 126.25 123.01 124.99 124.99 793,990
Feb 12, 2026 124.58 125.48 122.36 124.54 124.54 999,307
Feb 11, 2026 119.11 123.37 115.92 122.77 122.77 525,452
Feb 10, 2026 119.76 122.54 118.69 119.18 119.18 554,150
Feb 9, 2026 117.58 119.91 116.01 119.78 119.78 537,885
Feb 6, 2026 111.68 118.20 110.47 117.67 117.67 672,789
Feb 5, 2026 112.00 115.18 109.11 110.71 110.71 628,309
Feb 4, 2026 113.99 116.72 111.69 113.57 113.57 782,186
Feb 3, 2026 111.68 114.96 110.40 113.32 113.32 733,966
Feb 2, 2026 107.49 112.21 107.42 111.46 111.46 751,111
Jan 30, 2026 113.34 114.65 110.98 111.15 111.15 633,082
Jan 29, 2026 114.58 114.99 111.34 113.54 113.54 1,049,188
Jan 28, 2026 118.73 119.16 112.88 113.98 113.98 1,031,120
Jan 27, 2026 121.55 125.00 118.13 118.89 118.89 1,071,116
Jan 26, 2026 121.74 123.89 119.33 120.88 120.88 637,307
Jan 23, 2026 122.32 125.86 122.00 122.12 122.12 747,575
Jan 22, 2026 118.03 123.74 117.33 123.63 123.63 1,073,501
Jan 21, 2026 119.99 121.44 117.01 120.01 120.01 798,465
Jan 20, 2026 119.88 122.50 113.64 118.84 118.84 1,989,923
Jan 16, 2026 117.23 119.52 116.03 117.10 117.10 779,682
Jan 15, 2026 130.13 130.13 113.40 116.80 116.80 3,231,145
Jan 14, 2026 120.27 127.25 120.00 125.01 125.01 1,465,097
Jan 13, 2026 119.15 124.20 118.25 119.64 119.64 1,792,562
Jan 12, 2026 121.75 129.64 117.64 118.00 118.00 6,147,058
Jan 9, 2026 118.62 119.17 113.00 114.40 114.40 1,709,559
Jan 8, 2026 125.10 125.10 108.95 115.49 115.49 3,850,189
Jan 7, 2026 124.86 129.56 123.00 126.48 126.48 2,119,396
Jan 6, 2026 123.51 124.58 116.20 119.10 119.10 1,810,327
Jan 5, 2026 133.05 133.10 121.02 123.23 123.23 1,858,669
Jan 2, 2026 136.80 138.69 132.61 133.77 133.77 978,145
Dec 31, 2025 138.00 138.00 129.88 134.85 134.85 2,756,859
Dec 30, 2025 140.00 140.47 134.02 138.34 138.34 1,436,613
Dec 29, 2025 147.00 147.00 139.87 140.40 140.40 982,861
Dec 26, 2025 144.89 144.89 139.42 142.31 142.31 665,050
Dec 24, 2025 140.67 148.83 140.67 145.31 145.31 1,010,150
Dec 23, 2025 141.79 142.49 137.40 138.35 138.35 1,359,250
Dec 22, 2025 136.99 139.62 130.14 138.72 138.72 4,685,172
Dec 19, 2025 117.74 120.52 114.90 114.94 114.94 2,336,596
Dec 18, 2025 113.99 117.72 112.01 113.61 113.61 968,200
Dec 17, 2025 112.24 113.30 109.99 110.82 110.82 1,326,645
Dec 16, 2025 113.00 115.61 108.53 110.98 110.98 2,266,725
Dec 15, 2025 125.57 125.59 116.60 117.91 117.91 1,746,647
Dec 12, 2025 129.24 131.02 122.81 125.55 125.55 1,609,878
Dec 11, 2025 125.36 137.97 124.98 133.09 133.09 2,698,633
Dec 10, 2025 134.79 138.49 126.14 127.53 127.53 3,919,848
Dec 9, 2025 116.98 123.16 115.71 123.04 123.04 2,708,196
Dec 8, 2025 116.88 118.88 113.79 115.05 115.05 922,498
Dec 5, 2025 109.75 115.12 109.10 114.51 114.51 1,297,146
Dec 4, 2025 112.50 112.56 107.06 110.64 110.64 2,569,726
Dec 3, 2025 112.95 115.45 109.00 110.93 110.93 2,414,401
Dec 2, 2025 120.98 121.47 114.34 114.83 114.83 976,603
Dec 1, 2025 125.25 125.51 118.27 119.92 119.92 905,775
Nov 28, 2025 126.97 126.97 123.85 124.83 124.83 369,233
Nov 26, 2025 128.87 130.25 124.73 125.68 125.68 919,767
Nov 25, 2025 125.00 128.50 122.99 128.23 128.23 917,889
Nov 24, 2025 121.77 127.00 119.45 125.71 125.71 1,792,580
Nov 21, 2025 120.01 122.75 114.06 119.12 119.12 1,700,718
Nov 20, 2025 116.74 126.99 116.35 122.90 122.90 4,466,432
Nov 19, 2025 113.83 115.39 111.33 112.95 112.95 797,509
Nov 18, 2025 112.42 115.42 110.25 113.83 113.83 1,111,750
Nov 17, 2025 111.96 116.43 110.56 113.62 113.62 1,517,111
Nov 14, 2025 103.00 112.50 103.00 110.39 110.39 2,422,963
Nov 13, 2025 103.17 105.53 100.50 100.90 100.90 713,827
Nov 12, 2025 109.05 109.05 102.03 103.43 103.43 904,941
Nov 11, 2025 104.03 109.09 103.00 109.06 109.06 776,407
Nov 10, 2025 106.17 109.71 104.81 106.12 106.12 818,259
Nov 7, 2025 102.49 106.58 101.37 105.27 105.27 925,992
Nov 6, 2025 102.40 105.30 100.57 103.90 103.90 878,135
Nov 5, 2025 96.12 100.38 96.10 99.61 99.61 713,486
Nov 4, 2025 98.80 104.99 98.54 98.64 98.64 1,247,708
Nov 3, 2025 101.40 101.89 96.52 98.85 98.85 1,957,339
Oct 31, 2025 106.09 108.00 102.41 102.42 102.42 897,684
Oct 30, 2025 101.25 106.73 99.56 104.29 104.29 1,749,237
Oct 29, 2025 96.51 98.94 93.95 98.94 98.94 1,492,061
Oct 28, 2025 95.92 97.10 93.36 94.25 94.25 1,355,909
Oct 27, 2025 91.49 94.94 90.85 94.84 94.84 1,242,848
Oct 24, 2025 91.91 93.20 90.75 90.76 90.76 795,729
Oct 23, 2025 90.81 92.20 90.00 90.47 90.47 523,454
Oct 22, 2025 91.07 91.28 87.60 90.71 90.71 786,019
Oct 21, 2025 92.46 92.64 91.03 91.67 91.67 458,379
Oct 20, 2025 92.60 94.26 90.07 91.49 91.49 746,801
Oct 17, 2025 92.01 93.20 90.81 92.73 92.73 598,050
Oct 16, 2025 97.21 98.03 92.07 92.91 92.91 1,778,221
Oct 15, 2025 97.89 98.64 94.42 95.61 95.61 789,360
Oct 14, 2025 95.99 98.39 94.32 97.82 97.82 1,007,718
Oct 13, 2025 97.00 97.18 93.43 95.63 95.63 998,298
Oct 10, 2025 93.71 97.83 90.14 93.77 93.77 1,963,937
Oct 9, 2025 87.11 93.77 87.11 90.61 90.61 1,355,163
Oct 8, 2025 87.01 88.99 85.86 86.51 86.51 652,428
Oct 7, 2025 87.32 87.59 85.00 87.01 87.01 729,183
Oct 6, 2025 89.00 90.70 86.57 86.67 86.67 2,943,578
Oct 3, 2025 82.68 84.76 82.50 83.92 83.92 741,780
Oct 2, 2025 82.49 83.53 81.90 82.87 82.87 504,767
Oct 1, 2025 83.60 85.00 82.15 82.40 82.40 866,893
Sep 30, 2025 83.99 85.72 82.56 84.90 84.90 1,392,621
Sep 29, 2025 83.50 84.59 82.70 83.33 83.33 744,869
Sep 26, 2025 81.79 83.95 81.57 82.84 82.84 767,765
Sep 25, 2025 83.00 84.50 81.02 82.00 82.00 636,564
Sep 24, 2025 83.75 84.99 81.71 82.55 82.55 1,033,488
Sep 23, 2025 82.99 84.25 81.67 82.02 82.02 1,232,122

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Abivax SA American Depositary Shares Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ABVX, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation